ES2172584T3 - Preparacion administrable por via percutanea para tratar trastornos de la miccion. - Google Patents

Preparacion administrable por via percutanea para tratar trastornos de la miccion.

Info

Publication number
ES2172584T3
ES2172584T3 ES95918735T ES95918735T ES2172584T3 ES 2172584 T3 ES2172584 T3 ES 2172584T3 ES 95918735 T ES95918735 T ES 95918735T ES 95918735 T ES95918735 T ES 95918735T ES 2172584 T3 ES2172584 T3 ES 2172584T3
Authority
ES
Spain
Prior art keywords
disorders
treat
miction
administrable preparation
remedy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95918735T
Other languages
English (en)
Inventor
Katsuhiro Nakamura
Nobuyuki Koga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2172584T3 publication Critical patent/ES2172584T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PREPARACION ADMINISTRABLE PERCUTANEAMENTE PARA TRATAR TRASTORNOS URINARIOS QUE INCLUYE UN REMEDIO PARA LA ENFERMEDAD URINARIA Y UN ADHESIVO SENSIBLE A LA PRESION QUE CONTIENE POLIISOBUTILENOS DE BAJO Y ALTO PESO MOLECULAR Y UNA GRASA O ACEITE COMO BASE PRINCIPAL; Y OTRA PREPARACION QUE INCLUYE UN REMEDIO PARA LA ENFERMEDAD URINARIA Y UN ADHESIVO SENSIBLE A LA PRESION QUE CONTIENE POLISOBUTILENOS DE BAJO Y ALTO PESO MOLECULAR, UNA GRASA O ACEITE Y UN COPOLIMERO EN BLOQUE DE ESTIRENO-ISOPRENO- ESTIRENO COMO BASE PRINCIPAL. ESTAS PREPARACIONES, CONTIENEN LOS COMPONENTES DE BASE ARRIBA MENCIONADOS, TIENEN UNA EXCELENTE ESTABILIDAD INCLUSO CON EL PASO DEL TIEMPO, ESCASA IRRITABILIDAD DE LA PIEL, Y EXCELENTE ABSORBILIDAD PERCUTANEA.
ES95918735T 1994-05-18 1995-05-18 Preparacion administrable por via percutanea para tratar trastornos de la miccion. Expired - Lifetime ES2172584T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12816294 1994-05-18

Publications (1)

Publication Number Publication Date
ES2172584T3 true ES2172584T3 (es) 2002-10-01

Family

ID=14977927

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95918735T Expired - Lifetime ES2172584T3 (es) 1994-05-18 1995-05-18 Preparacion administrable por via percutanea para tratar trastornos de la miccion.

Country Status (8)

Country Link
US (1) US5770221A (es)
EP (1) EP0760238B1 (es)
KR (1) KR970703137A (es)
AU (1) AU2454495A (es)
DE (1) DE69526437T2 (es)
DK (1) DK0760238T3 (es)
ES (1) ES2172584T3 (es)
WO (1) WO1995031190A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989586A (en) * 1992-10-05 1999-11-23 Cygnus, Inc. Two-phase matrix for sustained release drug delivery device
US5879701A (en) * 1997-02-28 1999-03-09 Cygnus, Inc. Transdermal delivery of basic drugs using nonpolar adhesive systems and acidic solubilizing agents
US5843472A (en) * 1997-02-28 1998-12-01 Cygnus, Inc. Transdermal drug delivery sytem for the administration of tamsulosin, and related compositions and methods of use
JP4073517B2 (ja) * 1997-04-07 2008-04-09 久光製薬株式会社 経皮吸収貼付剤用粘着剤及び経皮吸収貼付剤
ATE399565T1 (de) * 1998-07-07 2008-07-15 Transdermal Technologies Inc Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
AU2940000A (en) * 1999-03-11 2000-09-28 Mitsubishi Chemical Corporation Drug composition for percutaneous absorption
AU3536799A (en) * 1999-04-26 2000-11-10 Lead Chemical Co., Ltd. Percutaneous preparations containing oxybutynin
TR200102583T2 (tr) * 1999-08-09 2002-07-22 Yamanouchi Pharmaceutical Co., Ltd. Alt idrar yolları semptomlarının tedavisine yönelik farmasötik bileşim.
WO2001021167A1 (en) * 1999-09-22 2001-03-29 Merck & Co., Inc. Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
ES2281366T3 (es) 1999-12-15 2007-10-01 Hisamitsu Pharmaceutical Co. Inc. Preparaciomnes de adhesivos.
CN1200696C (zh) 2000-04-18 2005-05-11 久光制药株式会社 含有抗炎药的贴剂
US6914169B1 (en) * 2000-05-19 2005-07-05 Hisamitsu Pharmaceutical., Inc. Patch agent
WO2002054996A2 (en) * 2000-10-23 2002-07-18 Euro Celtique Sa Terazosin transdermal device and methods
KR20050037405A (ko) * 2001-10-17 2005-04-21 히사미쯔 제약 주식회사 경피 흡수형 제제
JP4354678B2 (ja) 2002-08-28 2009-10-28 久光製薬株式会社 貼付剤
TWI296531B (en) * 2002-10-18 2008-05-11 Hisamitsu Pharmaceutical Co Transdermal adhesive preparations for topical administration of fentanyl
WO2005011683A1 (ja) * 2003-08-04 2005-02-10 Kyorin Pharmaceutical Co., Ltd. 経皮吸収型製剤
TWI335226B (en) * 2003-10-20 2011-01-01 Hisamitsu Pharmaceutical Co Adhesive preparations
DE10357321A1 (de) * 2003-12-05 2005-07-21 Tesa Ag Hochtackige Klebmasse, Verfahren zu deren Herstellung und deren Verwendung
DE102004009903A1 (de) 2004-02-26 2005-09-22 Grünenthal GmbH Pflaster mit reduzierter Hautirritation
JP5208348B2 (ja) * 2004-05-13 2013-06-12 旭化成ファーマ株式会社 ナフトピジルを含有する医薬
US20110071204A1 (en) * 2005-02-03 2011-03-24 Kyorin Pharmaceutical Co., Ltd. Percutaneous absorption preparation
KR20080000647A (ko) * 2005-04-28 2008-01-02 오노 야꾸힝 고교 가부시키가이샤 경피 흡수 제제
JP4921739B2 (ja) * 2005-08-10 2012-04-25 久光製薬株式会社 皮膚刺激を低減した貼付剤
JP4913738B2 (ja) * 2005-08-19 2012-04-11 ダイヤ製薬株式会社 プラスターの製造方法及びその製造装置及びプラスター用ライナー
JP4784875B2 (ja) 2006-04-11 2011-10-05 ニチバン株式会社 タムスロシン含有経皮吸収型製剤
US20100092544A1 (en) * 2008-10-14 2010-04-15 Katsuhiro Okada Adhesive composition for patch and use thereof
WO2013081014A1 (ja) * 2011-11-28 2013-06-06 株式会社 ケイ・エム トランスダーム 貼付剤
US10314791B2 (en) 2014-12-05 2019-06-11 KM Transderm Ltd. Adhesive sheet for attachment to skin and percutaneous absorption preparation using same
US11186564B2 (en) * 2016-08-04 2021-11-30 Sunovion Pharmaceuticals Inc. Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4262003A (en) * 1975-12-08 1981-04-14 Alza Corporation Method and therapeutic system for administering scopolamine transdermally
DE3344691A1 (de) * 1983-12-10 1985-06-20 Bayer Ag, 5090 Leverkusen Wirkstoffabgasesysteme
JPS6145052A (ja) * 1984-08-07 1986-03-04 有限会社 ▲カゲ▼山商事 桟瓦
EP0204968B1 (de) * 1985-05-24 1989-09-27 Beiersdorf Aktiengesellschaft Nitro-Pflaster
US4938759A (en) * 1986-09-02 1990-07-03 Alza Corporation Transdermal delivery device having a rate controlling adhesive
US4793337A (en) * 1986-11-17 1988-12-27 E. R. Squibb & Sons, Inc. Adhesive structure and products including same
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
JPH0725669B2 (ja) * 1988-12-23 1995-03-22 日東電工株式会社 経皮投与用医薬製剤
US5508038A (en) * 1990-04-16 1996-04-16 Alza Corporation Polyisobutylene adhesives for transdermal devices
JP2869167B2 (ja) * 1990-08-09 1999-03-10 日東電工株式会社 徐放性貼付製剤
JP3136413B2 (ja) * 1991-02-22 2001-02-19 リードケミカル株式会社 経皮吸収型頻尿・尿失禁治療剤
JPH04273818A (ja) * 1991-02-28 1992-09-30 Kissei Pharmaceut Co Ltd 経皮投与製剤
DE69326848T2 (de) * 1992-05-13 2000-01-27 Alza Corp Oxybutynin zur transdermalen Verabreichung
US5380760A (en) * 1993-11-19 1995-01-10 Minnesota Mining And Manufacturing Company Transdermal prostaglandin composition
US5503843A (en) * 1994-04-22 1996-04-02 Flora Inc. Transdermal delivery of alpha adrenoceptor blocking agents

Also Published As

Publication number Publication date
DE69526437T2 (de) 2002-10-31
DK0760238T3 (da) 2002-07-22
DE69526437D1 (de) 2002-05-23
EP0760238B1 (en) 2002-04-17
EP0760238A1 (en) 1997-03-05
KR970703137A (ko) 1997-07-03
WO1995031190A1 (en) 1995-11-23
AU2454495A (en) 1995-12-05
EP0760238A4 (en) 1998-06-03
US5770221A (en) 1998-06-23

Similar Documents

Publication Publication Date Title
ES2172584T3 (es) Preparacion administrable por via percutanea para tratar trastornos de la miccion.
MX9102501A (es) Derivados de metano sulfonamida, composiciones farderivados de metanosulfonamida, composiciones farmaceuticas que los contienen y procedimiento para smaceuticas que los contienen y procedimiento para u preparacion. su preparacion.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
JO1425B1 (en) New vehicles
ES2057604T3 (es) Enantiomero r de n-propargil-1-aminoindano, su preparacion y composiciones farmaceuticas que lo contienen.
BRPI0510770A (pt) derivados de fluorglicosìdeos de pirazóis, medicamentos contendo esses compostos e seu uso
GT199900022A (es) Compuestos para el tratamiento de la isquemia
GT199900102A (es) Fenoxipropanolaminas, procedimiento para su preparacìon y composiciones farmacèuticasque las contienen.
BR0014817A (pt) Imidazo-5-il-aminas bicìclicas, medicamentos que as contém, seu emprego para a preparação de medicamentos e procedimento para sua preparação
ES2190205T3 (es) Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda.
BR9706386A (pt) Antagonistas do receptor de vitronectina, sua preparação e seu us0
Moccia et al. Fascial bundles of the infraspinatus fascia: anatomy, function, and clinical considerations
AR005860A1 (es) Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización.
ES2132241T3 (es) Composiciones oftalmicas y metodos para su conservacion y su empleo.
ES2061828T3 (es) Composiciones antiirritantes y desensibilizadoras y metodos para su uso.
BR0114082A (pt) Compostos, composições farmacêuticas, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
ES2059130T3 (es) Composiciones farmaceuticas que contienen ipriflavona, procedimiento para su preparacion y uso terapeutico relacionado.
ES2062997T3 (es) Vinilcefalosporinas sustituidas, procedimiento para su fabricacion y su uso como medicamento.
BR0012127A (pt) Compostos de xantona, sua preparação e uso como medicamento
MX9204239A (es) Quinolin-2-il-metoxibencilhindroxiureas, procedimiento para su preparacion y medicamentos que las contienen.
ES2139156T3 (es) Sulfonamidas sustituidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
MX9201912A (es) Nuevas sulfonamidas, procedimiento para su preparacion y preparado farmaceutico que las contiene.
Intumbo Papiamentu, Guiné-Bissau Creole Portuguese, and its substrate, Balanta: A comparison of the noun phrase
ES2188232T3 (es) Uso de cetirizina para impedir la aparicion del asma.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 760238

Country of ref document: ES